Clinical Report: Highlights from the 2026 Global Specialty Lens Symposium
Overview
The 2026 Global Specialty Lens Symposium showcased significant advancements in myopia management and specialty lens care. Key discussions centered on the latest evidence-based practices and regulatory milestones impacting pediatric myopia treatment.
Background
The management of myopia, particularly in pediatric populations, is a critical area of focus in ophthalmology due to its increasing prevalence and potential long-term vision impairment. Recent updates from the International Myopia Institute and regulatory approvals, such as the FDA's clearance of the Essilor Stellest lens, underscore the importance of evolving treatment strategies. Specialty lenses, including scleral lenses for keratoconus, also represent a growing field of interest at such symposiums.
Data Highlights
No numerical data was presented in the article.
Key Findings
- Myopia management standards are rapidly evolving, emphasizing optical interventions as first-line options.
- The FDA granted De Novo marketing authorization to Essilor Stellest, the first spectacle lens aimed at slowing pediatric myopia progression.
- Multifocal soft contact lenses have been shown to reduce myopia progression compared to single-vision corrections.
- Continuing myopia treatment into later teen years helps sustain axial-length control after cessation.
- Recent studies reaffirm the safety and effectiveness of orthokeratology in managing myopia.
Clinical Implications
Healthcare professionals should stay updated on the latest myopia management strategies and consider incorporating newly approved treatments into their practice. Emphasizing hygiene and follow-up care is crucial, especially with the use of specialty lenses like orthokeratology.
Conclusion
The 2026 Global Specialty Lens Symposium highlighted critical advancements in myopia management and specialty lens applications, reinforcing the need for clinicians to adopt evidence-based practices in their care strategies.
Related Resources & Content
- Contact Lens Spectrum, 2025 -- At the Show - Day 2
- Contact Lens Spectrum, 2025 -- At the Show - Day 1
- Contact Lens Spectrum, 2025 -- At the Show - Day 3
- IMI—2025 Digest - PMC, 2025
- Long-Term Effectiveness of Scleral Lens Treatment in the Management of Keratoconus: A Systematic Review - PMC
- Eyecare Business — VEE PREVIEW
- Eyecare Business — VEE PREVIEW
- IMI—2025 Digest - PMC
- Long-Term Effectiveness of Scleral Lens Treatment in the Management of Keratoconus: A Systematic Review - PMC
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.


